Patents by Inventor TODD M. OPPENEER

TODD M. OPPENEER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT OSTEOARTHRITIS
    Publication number: 20220160836
    Abstract: The disclosure relates to the use of variants of C-type natriuretic peptide (CNP) to treat osteoarthritis, to ameliorate one or more symptoms of osteoarthritis, and to treat disorders having an osteoarthritis component.
    Type: Application
    Filed: December 3, 2021
    Publication date: May 26, 2022
    Inventors: Charles A. O'Neill, Todd M. Oppeneer, Jason K. Pinkstaff
  • Use of C-type natriuretic peptide variants to treat osteoarthritis
    Patent number: 11202819
    Abstract: The disclosure relates to the use of variants of C-type natriuretic peptide (CNP) to treat osteoarthritis, to ameliorate one or more symptoms of osteoarthritis, and to treat disorders having an osteoarthritis component.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: December 21, 2021
    Assignee: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Charles A. O'Neill, Todd M. Oppeneer, Jason K. Pinkstaff
  • USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT OSTEOARTHRITIS
    Publication number: 20190247467
    Abstract: The disclosure relates to the use of variants of C-type natriuretic peptide (CNP) to treat osteoarthritis, to ameliorate one or more symptoms of osteoarthritis, and to treat disorders having an osteoarthritis component.
    Type: Application
    Filed: December 8, 2016
    Publication date: August 15, 2019
    Applicant: BIOMARIN PHARMACEUTICAL INC.
    Inventors: CHARLES A. O'NEILL, TODD M. OPPENEER, JASON K. PINKSTAFF